Neutral impactStocks
Q2 Results Today Highlights: Tata Consumer Q2 profit declines, Aequs, Dalmia Bharat PAT declines q-o-q, Ather Energy & ITC Hotels jump after Q2 results, BoM, TMB, IOB, Mankind Pharma, APL Apollo Q2 PAT rise, Paytm, KFin Tech, Nazara to announce Q2 results
BusinessLine 1 hr ago·26 Oct 2026, 3:27 pm
Mankind Pharma is set to announce its second-quarter results for the current financial year. Investors will closely watch the company's earnings report to gauge its financial health and growth trajectory.
The announcement is significant as it will provide insights into the company's performance amid a competitive pharmaceutical landscape. Market participants will be looking for updates on revenue growth, profit margins, and future outlook.
Investors should pay attention to the management commentary regarding the company's strategy and market conditions. The results will help determine the stock's short-term and long-term investment potential.
Excerpt from BusinessLine
Q 2 Results Today, 26th October 2026 Highlights: Find all the latest Q2 results 2026 updates of 7NR Retail, AAVAS Financiers, Aditya Birla Real Estate, Acceleratebs India, Acevector, Achyut Healthcare, Admach Systems, Ad-Manum Finance, Aegis Logistics, Aegis Vopak Terminals, Aequs, Alphalogic Industries, Antelopus…Read the original at BusinessLine
Affected stocks
Neutral8 stocks
Mankind Pharma
MANKIND Neutral
₹2,312.00
DALBHARAT
DALBHARAT Neutral
—
ATHERENERG
ATHERENERG Neutral
—
ITCHOTELS
ITCHOTELS Neutral
—
APL
APL Neutral
—
IOB
IOB Neutral
—
TMB
TMB Neutral
—
TATACONSUM
TATACONSUM Neutral
—
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Mankind Pharma (MANKIND).
- Category: Stocks.
- Assessed as a significant, market-relevant update.
- Also mentions DALBHARAT, ATHERENERG, ITCHOTELS.
Why it matters
A meaningful update for Mankind Pharma worth tracking. Use the price and stock snapshot to gauge how the market is responding.
